The sponsor of a clinical trial plays a key role in the development of new medicinal products and medical devices. The sponsor initiates the trial, defines its objectives, provides funding, and is responsible for compliance with applicable legislation, international Good Clinical Practice (GCP) standards, and the protection of participants’ rights.
Despite the common misconception, the sponsor is not merely a source of funding. The sponsor organizes the entire life cycle of a clinical trial, from developing the concept and preparing documentation to analyzing the results and interacting with regulatory authorities. At the same time, certain functions may be transferred to a Contract Research Organization (CRO); however, responsibility for the quality of the trial and the safety of participants always remains with the sponsor.
What Is a Clinical Trial Sponsor?According to the ICH GCP E6(R3) guideline, a sponsor is an individual, company, organization, or institution that assumes responsibility for initiating, organizing, financing, and managing a clinical trial.
Sponsors may include:
- pharmaceutical companies;
- biotechnology companies;
- medical device manufacturers;
- research institutes;
- universities;
- healthcare organizations;
- government institutions.
The sponsor’s primary responsibility is not limited to financing the project but also includes ensuring its scientific, ethical, and regulatory soundness.
Main Responsibilities of the SponsorThe sponsor is responsible for all key stages of organizing and conducting a clinical trial.
The sponsor’s responsibilities include:
- developing the trial concept and selecting the study design;
- preparing the protocol and other required documentation;
- assessing the benefit-risk ratio;
- selecting investigational sites;
- organizing monitoring;
- implementing a quality management system;
- managing clinical data;
- ensuring pharmacovigilance;
- interacting with regulatory authorities;
- analyzing the results of the clinical trial.
All processes must comply with GCP requirements and applicable legislation.
Can a Sponsor Transfer Its Functions to a CRO?Most modern clinical trials are conducted with the involvement of Contract Research Organizations (CROs). CROs help sponsors organize and perform specific processes using specialized teams and accumulated expertise.
A CRO may be responsible for:
- project management;
- clinical trial monitoring;
- preparation of documentation;
- interaction with regulatory authorities;
- communication with investigational sites;
- data management;
- biostatistical analysis;
- pharmacovigilance;
- auditing;
- preparation of registration documentation.
However, even when certain functions are transferred to a CRO, the ultimate responsibility for the conduct of the clinical trial remains with the sponsor. This is one of the fundamental principles of ICH GCP E6(R3).
How to Choose a CRO?When selecting a Contract Research Organization, it is recommended to consider:
- experience in conducting trials of the relevant phase;
- the qualifications of the team;
- the availability of a quality management system;
- experience in the required therapeutic area;
- capabilities in monitoring, data management, and pharmacovigilance;
- successful experience in interacting with regulatory authorities;
- a proven track record of meeting project timelines;
- the project budget.
A comprehensive approach by a CRO can help reduce organizational risks and improve the efficiency of clinical trial conduct.
Common MisconceptionsThe Sponsor Only Finances the Clinical TrialThis is incorrect. Financing is only one of the sponsor’s functions. The sponsor is responsible for organizing the trial, maintaining the quality system, managing risks, and ensuring the reliability of the data obtained.
Once the Project Is Transferred to a CRO, Responsibility Is Transferred to the ContractorNo. Delegating specific functions does not relieve the sponsor of responsibility. According to ICH GCP E6(R3), the sponsor remains responsible for ensuring that the trial complies with GCP requirements and for the safety of participants.
Only a Pharmaceutical Company Can Be a SponsorNo. Depending on the objectives of the trial, sponsors may also include universities, research organizations, healthcare institutions, and government bodies.
ConclusionThe sponsor of a clinical trial is a central figure in the development of new medicinal products and medical devices. The sponsor is responsible for the scientific rationale of the project, organization of the trial, quality management, participant safety, and reliability of clinical data.
To ensure effective project implementation, the sponsor may delegate certain functions to a Contract Research Organization. However, responsibility for the conduct of the trial, compliance with GCP requirements, and fulfillment of regulatory requirements remains with the sponsor throughout the entire project life cycle.
Cooperation with an experienced CRO makes it possible to optimize processes, reduce organizational risks, and ensure that clinical trials are conducted in accordance with international quality standards and applicable regulatory requirements.
Vita Aeterna is a Contract Research Organization (CRO) providing sponsors with comprehensive support throughout the clinical trial process. We can take on individual functions or provide a full range of services, from documentation preparation, selection and communication with investigational sites, and monitoring to data management, pharmacovigilance, statistical analysis, and regulatory support. With more than 13 years of experience and over 350 completed projects, we provide professional clinical trial management in compliance with GCP requirements and applicable legislation.